Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17853334rdf:typepubmed:Citationlld:pubmed
pubmed-article:17853334lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17853334lifeskim:mentionsumls-concept:C1556085lld:lifeskim
pubmed-article:17853334lifeskim:mentionsumls-concept:C0025267lld:lifeskim
pubmed-article:17853334lifeskim:mentionsumls-concept:C0220908lld:lifeskim
pubmed-article:17853334lifeskim:mentionsumls-concept:C1511726lld:lifeskim
pubmed-article:17853334lifeskim:mentionsumls-concept:C0679199lld:lifeskim
pubmed-article:17853334lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:17853334lifeskim:mentionsumls-concept:C1561491lld:lifeskim
pubmed-article:17853334lifeskim:mentionsumls-concept:C1704419lld:lifeskim
pubmed-article:17853334lifeskim:mentionsumls-concept:C1527178lld:lifeskim
pubmed-article:17853334pubmed:issue8lld:pubmed
pubmed-article:17853334pubmed:dateCreated2007-9-13lld:pubmed
pubmed-article:17853334pubmed:abstractTextMultiple-endocrine-neoplasia-type-1 (MEN1) is an autosomal-dominant inherited disorder characterized by the combined occurrence of primary hyperparathyroidism (pHPT), gastroenteropancreatic neuroendocrine tumors (GEP), adenomas of the pituitary gland (APA), adrenal cortical tumors (ADR) and other tumors. As the tumors appear in an unpredictable schedule, uncertainty about screening programs is persisting.lld:pubmed
pubmed-article:17853334pubmed:languageenglld:pubmed
pubmed-article:17853334pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17853334pubmed:citationSubsetIMlld:pubmed
pubmed-article:17853334pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17853334pubmed:statusMEDLINElld:pubmed
pubmed-article:17853334pubmed:monthSeplld:pubmed
pubmed-article:17853334pubmed:issn0947-7349lld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:SchaafLLlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:SpelsbergFFlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:von zur...lld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:SchneyerUUlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:HenselHHlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:RothmundMMlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:DralleHHlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:ZinnerKKlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:RaueFFlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:GerlHHlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:GoretzkiP EPElld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:StallaG KGKlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:HöppnerWWlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:EngelbachMMlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:KargesWWlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:PickerLLlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:HöflerMMlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:HeringUUlld:pubmed
pubmed-article:17853334pubmed:authorpubmed-author:BartschD KDKlld:pubmed
pubmed-article:17853334pubmed:issnTypePrintlld:pubmed
pubmed-article:17853334pubmed:volume115lld:pubmed
pubmed-article:17853334pubmed:ownerNLMlld:pubmed
pubmed-article:17853334pubmed:authorsCompleteYlld:pubmed
pubmed-article:17853334pubmed:pagination509-17lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:meshHeadingpubmed-meshheading:17853334...lld:pubmed
pubmed-article:17853334pubmed:year2007lld:pubmed
pubmed-article:17853334pubmed:articleTitleDeveloping effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1.lld:pubmed
pubmed-article:17853334pubmed:affiliationEndocrinology and Clinical Chemistry, Max-Planck-Institute of Psychiatry, Kraepelinstrasse 10, 80804 Munich, Germany. schaaf@mpipsykl.mpg.delld:pubmed
pubmed-article:17853334pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:4221entrezgene:pubmedpubmed-article:17853334lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17853334lld:entrezgene